|
US5641628A
(en)
|
1989-11-13 |
1997-06-24 |
Children's Medical Center Corporation |
Non-invasive method for isolation and detection of fetal DNA
|
|
WO1994002156A1
(en)
|
1992-07-16 |
1994-02-03 |
The Board Of Trustees Of Leland Stanford Junior University |
Methods for using dendritic cells to activate t cells
|
|
US6821778B1
(en)
|
1993-12-01 |
2004-11-23 |
The Board Of Trustees Of Leland Stanford Junior University |
Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells
|
|
ES2153895T3
(es)
|
1994-03-08 |
2001-03-16 |
Dana Farber Cancer Inst Inc |
Metodos para modular la insensibilidad de celulas t.
|
|
AUPM446594A0
(en)
|
1994-03-16 |
1994-04-14 |
Csl Limited |
Cytotoxic t-cell epitopes identified within epstein-barr virus
|
|
PT772624E
(pt)
|
1994-04-06 |
2001-03-30 |
Immunex Corp |
Interleucina-15
|
|
ES2186686T3
(es)
|
1994-05-16 |
2003-05-16 |
Roche Diagnostics Gmbh |
Metodo de inmunomodulacion por medio de transferencia adoptiva de linfocitos t-citotoxicos especificos de antigenos.
|
|
US6300090B1
(en)
|
1994-07-29 |
2001-10-09 |
The Rockefeller University |
Methods of use of viral vectors to deliver antigen to dendritic cells
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
PT747481E
(pt)
|
1995-06-06 |
2002-05-31 |
Organon Teknika Bv |
Peptidos do virus de epstein-barr e anticorpos contra estes peptidos
|
|
FR2745185B1
(fr)
|
1996-02-28 |
1998-05-15 |
Sanofi Sa |
Utilisation de l'il-7 dans le traitement des maladies auto-immunes, en particulier le diabete mellitus insulinodependant
|
|
US6703024B2
(en)
|
1996-05-24 |
2004-03-09 |
The Council Of The Queensland Institute Of Medical Research |
EBV CTL epitopes
|
|
US5962318A
(en)
|
1996-11-15 |
1999-10-05 |
St. Jude Children's Research Hospital |
Cytotoxic T lymphocyte-mediated immunotherapy
|
|
JP2001509677A
(ja)
|
1997-01-31 |
2001-07-24 |
エピミューン，インコーポレイティド |
Ｃｔｌを活性化するためのペプチドおよびペプチド担持抗原提示細胞
|
|
WO1998049270A1
(en)
|
1997-04-25 |
1998-11-05 |
The Wistar Institute Of Anatomy And Biology |
Cytolytic t-cell clones against colorectal carcinoma and methods of use thereof
|
|
US7951383B2
(en)
*
|
1997-05-23 |
2011-05-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated parainfluenza virus (PIV) vaccines
|
|
AUPO784197A0
(en)
|
1997-07-10 |
1997-08-07 |
Csl Limited |
Treatment of nasopharyngeal carcinoma
|
|
DE69840739D1
(de)
|
1997-10-27 |
2009-05-28 |
Merix Bioscience Inc |
Methode und Zusammensetzung zur Herstellung von reifen dendritischen Zellen
|
|
US20020155108A1
(en)
|
1998-05-04 |
2002-10-24 |
Biocrystal, Ltd. |
Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells
|
|
WO2000050569A1
(en)
*
|
1999-02-24 |
2000-08-31 |
The Wistar Institute Of Anatomy And Biology |
Method of modifying cytotoxic cells and uses thereof
|
|
US6828147B1
(en)
|
1999-02-24 |
2004-12-07 |
The Wistar Institute Of Anatomy And Biology |
Method of modifying cytotoxic cells and uses thereof
|
|
US7005131B1
(en)
|
1999-08-13 |
2006-02-28 |
The Rockefeller University |
Protective antigen of Epstein Barr Virus
|
|
US20150037297A1
(en)
|
1999-08-30 |
2015-02-05 |
David S Terman |
Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
|
|
DK1231840T3
(da)
|
1999-11-24 |
2009-11-23 |
Red Cliff Holding |
Anti-angiogent cellulært middel til cancerterapi
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US20020155127A1
(en)
|
2000-06-02 |
2002-10-24 |
Danher Wang |
Genetic vaccine against human immunodeficiency virus
|
|
DK1297017T3
(da)
|
2000-06-19 |
2012-09-17 |
Dana Farber Cancer Inst Inc |
Sammensætninger og fremgangsmåder med monoklonale og polyklonale antistoffer, der er specifikke for T-cellesubpopulationer
|
|
DK1326961T3
(da)
|
2000-09-15 |
2008-01-07 |
Ortho Mcneil Pharm Inc |
Sammensætninger og fremgangsmåder tl inducering af specifikke cytolytiske T-cellereaktioner
|
|
EP1229043A1
(en)
|
2001-01-30 |
2002-08-07 |
Cyto-Barr B.V. |
Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith
|
|
GB0107628D0
(en)
|
2001-03-27 |
2001-05-16 |
Avidex Ltd |
Substances
|
|
US20040022761A1
(en)
|
2001-05-11 |
2004-02-05 |
Banchereau Jacques F |
Compositions and methods for producing antigen-presenting cells
|
|
EP1407004B1
(en)
|
2001-05-15 |
2009-08-05 |
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease
|
|
ATE312505T1
(de)
|
2001-09-28 |
2005-12-15 |
Heinrich-Guenter Schumacher |
Mähmesser mit einer aus teilschienen zusammengesetzten messerschiene
|
|
EP1444330A1
(en)
|
2001-11-07 |
2004-08-11 |
Kirin Beer Kabushiki Kaisha |
Expansion of t cells in vitro and expanded t cell populations
|
|
US20030148982A1
(en)
|
2001-11-13 |
2003-08-07 |
Brenner Malcolm K. |
Bi-spcific chimeric T cells
|
|
DK1448229T3
(da)
|
2001-11-29 |
2010-03-08 |
Dandrit Biotech As |
Farmaceutisk sammensætning til at inducere et immunrespons hos et menneske eller et dyr
|
|
US20040096457A1
(en)
|
2001-12-11 |
2004-05-20 |
Huber Brigitte T |
Treatment and prevention of ebv infection and ebv-associated disorders
|
|
AU2003202908A1
(en)
|
2002-01-03 |
2003-07-24 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
WO2004041849A1
(en)
|
2002-11-07 |
2004-05-21 |
The Council Of The Queensland Institute Of Medical Research |
Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
|
|
AU2002953238A0
(en)
|
2002-12-09 |
2003-01-02 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
In vitro immunization
|
|
IL158140A0
(en)
|
2003-09-25 |
2004-03-28 |
Hadasit Med Res Service |
Multiepitope polypeptides for cancer immunotherapy
|
|
CN101120083B
(zh)
|
2003-10-08 |
2013-03-27 |
威尔森沃尔夫制造公司 |
利用透气性材料进行细胞培养的方法及装置
|
|
US20050221481A1
(en)
|
2004-03-30 |
2005-10-06 |
Istituto Superiore Di Sanita' |
Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2
|
|
US7785806B2
(en)
*
|
2004-04-28 |
2010-08-31 |
Vaxdesign Corporation |
Method for determining the immunogenicity of an antigen
|
|
CA2568344C
(en)
*
|
2004-05-27 |
2016-01-19 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
US7785875B2
(en)
|
2004-07-03 |
2010-08-31 |
Mogam Biotechnology Research Institute |
Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same
|
|
US20060045883A1
(en)
|
2004-08-26 |
2006-03-02 |
Jeffrey Molldrem |
Anti-cancer vaccines
|
|
JP4731867B2
(ja)
|
2004-10-01 |
2011-07-27 |
国立大学法人三重大学 |
Ｃｄ８陽性の細胞傷害性ｔリンパ球の誘導方法
|
|
US20060204509A1
(en)
|
2005-03-14 |
2006-09-14 |
Harty John T |
Accelerated CD8+ T-cell memory after dendritic cell vaccination
|
|
EP1712615A1
(en)
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
ES2334936T3
(es)
|
2005-04-20 |
2010-03-17 |
F. Hoffmann-La Roche Ag |
Metodo de identificacion de epitopos relacionados con la inmunogenicidad en biofarmacos.
|
|
AU2006247802A1
(en)
|
2005-05-11 |
2006-11-23 |
The Trustees Of The University Of Pennsylvania |
Methods for the rapid expansion of antigen specific T-cells
|
|
US20070003531A1
(en)
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
|
US20100035282A1
(en)
|
2005-08-03 |
2010-02-11 |
Maria Chiara Bonini |
Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes
|
|
JP4824389B2
(ja)
|
2005-10-28 |
2011-11-30 |
株式会社医学生物学研究所 |
エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途
|
|
CA2630218A1
(en)
|
2005-11-18 |
2007-08-30 |
The Ohio State University Research Foundation |
Viral gene products and methods for vaccination to prevent viral associated diseases
|
|
CA2644540C
(en)
|
2006-03-02 |
2014-09-30 |
Antitope Limited |
T cell assays
|
|
GB0604170D0
(en)
|
2006-03-02 |
2006-04-12 |
Antitope Ltd |
T cell assays
|
|
US20070243549A1
(en)
|
2006-04-12 |
2007-10-18 |
Biocept, Inc. |
Enrichment of circulating fetal dna
|
|
WO2008025992A2
(en)
|
2006-09-01 |
2008-03-06 |
Cambridge Enterprise Limited |
Methods of expanding non-effector cd8 t-cell populations
|
|
EP2091961A4
(en)
|
2006-11-22 |
2009-12-09 |
Univ Arkansas |
IMMUNOTHERAPY AGAINST CANCER WITH MULTIPPITOP-PEPTIDE-LOADED DENDRITIC CELLS
|
|
CN101611133A
(zh)
|
2006-12-07 |
2009-12-23 |
威尔森沃尔夫制造公司 |
高效装置及培养细胞的方法
|
|
JP2010512324A
(ja)
|
2006-12-08 |
2010-04-22 |
アッテヌオン エル エル シー |
ウロキナーゼ型プラスミノーゲン活性化因子受容体エピトープ、それに由来するモノクローナル抗体及びそれらの使用方法
|
|
DE102006060824B4
(de)
*
|
2006-12-21 |
2011-06-01 |
Johannes-Gutenberg-Universität Mainz |
Nachweis von individuellen T-Zell-Reaktionsmustern gegen Tumor-assoziierte Antigene (TAA) in Tumorpatienten als Basis für die individuelle therapeutische Vakzinierung von Patienten
|
|
WO2008148170A1
(en)
*
|
2007-06-08 |
2008-12-11 |
The University Of Queensland |
Human metapneumovirus immunogenic peptides, compositions, and methods of use
|
|
US8546137B2
(en)
|
2007-09-27 |
2013-10-01 |
The Board Of Trustees Of The University Of Arkansas |
Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor
|
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
US20100254958A1
(en)
|
2007-10-24 |
2010-10-07 |
Anne Letsch |
Antigen-Specific T-Cell Preparations from Bone Marrow
|
|
EP2215111B1
(en)
|
2007-11-01 |
2016-03-16 |
Mayo Foundation For Medical Education And Research |
Hla-dr binding peptides and their uses
|
|
EP2065462A1
(en)
|
2007-11-27 |
2009-06-03 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens
|
|
CA2736851A1
(en)
|
2008-09-11 |
2010-03-18 |
Lung-Ji Chang |
System and method for producing t cells
|
|
CN101824400B
(zh)
|
2009-03-05 |
2012-08-08 |
中国科学院微生物研究所 |
一种放大增殖抗原特异性t细胞的方法
|
|
KR20120059581A
(ko)
|
2009-08-24 |
2012-06-08 |
윌슨 울프 매뉴팩처링 |
다중 종양 항원 또는 다중 바이러스에 대해 특이성을 갖는 ｃｔｌ주의 생성
|
|
WO2011024482A1
(ja)
|
2009-08-29 |
2011-03-03 |
株式会社バイオメッドコア |
抗原特異的ｔ細胞誘導能測定法
|
|
GB0917090D0
(en)
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
JP2013512694A
(ja)
|
2009-12-08 |
2013-04-18 |
ウィルソン ウォルフ マニュファクチャリング コーポレイション |
養子細胞療法のための細胞を培養する方法
|
|
US20130115617A1
(en)
|
2009-12-08 |
2013-05-09 |
John R. Wilson |
Methods of cell culture for adoptive cell therapy
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
KR102095670B1
(ko)
*
|
2010-05-14 |
2020-03-31 |
더 제너럴 하스피톨 코포레이션 |
종양 특이적 신생항원을 확인하는 조성물 및 방법
|
|
WO2011146473A1
(en)
|
2010-05-17 |
2011-11-24 |
Duke University |
Methods of treatment using ex vivo expansion of cord blood t cells
|
|
WO2012017033A1
(en)
|
2010-08-04 |
2012-02-09 |
Ieo-Istituto Europeo Di Oncologia S.R.L. |
Method of antigen loading for immunotherapy
|
|
US8741642B2
(en)
|
2010-10-22 |
2014-06-03 |
Virginia Commonwealth University |
Methods for producing autologous immune cells resistant to myeloid-derived suppressor cells effects
|
|
EP2453243A1
(en)
|
2010-11-11 |
2012-05-16 |
Cosmo S.p.A. |
Method for the diagnosis and/or follow up of the evolution of a tumor
|
|
US20130045491A1
(en)
|
2011-07-19 |
2013-02-21 |
Derya Unutmaz |
Methods for activating t cells
|
|
BR112014005355B1
(pt)
|
2011-09-08 |
2022-03-29 |
Yeda Research An Development Co., Ltd |
Células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença
|
|
GB201121308D0
(en)
|
2011-12-12 |
2012-01-25 |
Cell Medica Ltd |
Process
|
|
JP6081483B2
(ja)
|
2011-12-12 |
2017-02-15 |
セル・メディカ・リミテッド |
Ｔ細胞を増殖させるプロセス
|
|
EP2812431B1
(en)
|
2012-02-09 |
2019-07-17 |
Baylor College Of Medicine |
Pepmixes to generate multiviral ctls with broad specificity
|
|
US20130217122A1
(en)
|
2012-02-21 |
2013-08-22 |
The Trustees Of The University Of Pennsylvania |
Expansion of Interferon-Gamma-Producing T-Cells Using Glypican-3 Peptide Library
|
|
WO2013169922A1
(en)
|
2012-05-08 |
2013-11-14 |
Western University Of Health Sciences |
Standardized ex vivo platforms for the antigen-specific expansion of cd4+ t cell populations
|
|
EP3071686B1
(en)
|
2013-11-22 |
2020-07-22 |
Cellectis SA |
Method for generating batches of allogeneic t-cells with averaged potency
|
|
EP3097416A2
(en)
*
|
2014-01-21 |
2016-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for testing t cell priming efficacy in a subject
|
|
WO2016073595A1
(en)
|
2014-11-05 |
2016-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
T cells and dendritic cells for polyomavirus therapy
|
|
TWI673365B
(zh)
|
2014-11-05 |
2019-10-01 |
美國紀念斯隆 凱特琳癌症中心 |
選擇用於過繼性細胞療法之ｔ細胞株及其供體之方法
|
|
WO2016154112A1
(en)
|
2015-03-20 |
2016-09-29 |
Children's National Medical Center |
Generating virus or other antigen-specific t cells from a naive t cell population
|
|
EP3313419B1
(en)
|
2015-06-26 |
2020-08-19 |
Memorial Sloan Kettering Cancer Center |
Methods of treating cmv retinitis by t cell therapy
|
|
IL298359B2
(en)
|
2015-09-18 |
2025-12-01 |
Baylor College Medicine |
Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
|
|
MX2018013959A
(es)
|
2016-05-25 |
2019-08-22 |
Council Queensland Inst Medical Res |
Metodos para tratar enfermedad autoinmune usando celulas t alogenicas.
|
|
JP7002769B2
(ja)
|
2016-09-16 |
2022-02-04 |
ベイラー カレッジ オブ メディスン |
ウイルス特異的ｔ細胞の活性化および拡大のためのプラットフォーム
|
|
TW201814042A
(zh)
|
2016-09-26 |
2018-04-16 |
新加坡商泰莎治療私人有限公司 |
T細胞擴展方法
|
|
EP3641807A4
(en)
|
2017-06-22 |
2021-04-21 |
The Westmead Institute For Medical Research |
Adoptive t cell therapy 2
|
|
AU2018330415A1
(en)
|
2017-09-06 |
2020-03-19 |
Nant Holdings Ip, Llc |
HLA tissue matching and methods therefor
|
|
GB201808651D0
(en)
|
2018-05-25 |
2018-07-11 |
Rolls Royce Plc |
Rotor blade arrangement
|
|
MX2021011622A
(es)
|
2019-03-25 |
2022-01-04 |
Baylor College Medicine |
Células t específicas de antígeno de multiples virus respiratorios y métodos para elaborar y usar las mismas de manera terapéutica.
|
|
TWI867324B
(zh)
|
2019-05-08 |
2024-12-21 |
美商百歐恩泰美國公司 |
T細胞製備組合物及方法
|
|
MA56534A
(fr)
|
2019-06-20 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Co |
Administration par nanoporteurs glucidiques, de vaccins contre le virus de l'hépatite b (vhb)
|
|
US20220257654A1
(en)
|
2019-07-23 |
2022-08-18 |
Baylor College Of Medicine |
Antigen-specific t cell banks and methods of making and using the same therapeutically
|
|
CA3149145A1
(en)
|
2019-07-29 |
2021-02-04 |
Baylor College Of Medicine |
Antigen-specific t cell banks and methods of making and using the same therapeutically
|
|
US20220288119A1
(en)
|
2019-08-16 |
2022-09-15 |
Baylor College Of Medicine |
Third party virus-specific t cell compositions, and methods of making and using the same in anti-viral prophylaxis
|
|
US20230028788A1
(en)
|
2019-12-23 |
2023-01-26 |
Baylor College Of Medicine |
T cell performance assay as a prognostic factor for clinical outcome
|
|
JP2023518792A
(ja)
|
2020-03-20 |
2023-05-08 |
ベイラー カレッジ オブ メディスン |
ＳＡＲＳ－ＣｏＶ２特異的Ｔ細胞組成物ならびにコロナウイルスおよび他の呼吸器系ウイルス感染症の処置および予防におけるそれらの使用
|
|
EP3974029A1
(en)
|
2020-09-25 |
2022-03-30 |
Universidad Autónoma de Madrid |
Memory t cells as adoptive cell therapy for viral infections
|